Allstate
ALL
$253.83
-0.28%
The Allstate Corporation is a major US property-casualty insurer, offering personal auto, homeowners, and other insurance products primarily through its network of about 6,000 exclusive agents. As one of the largest insurers in the US, Allstate holds a strong competitive position in the personal lines market, leveraging its brand recognition and extensive agency distribution. The current investor narrative centers on a 'quiet catastrophe year' with significantly lower catastrophe losses and policy growth, which is expected to drive exceptional earnings in Q2 2026. Additionally, higher interest rates are benefiting insurers through wider margins and better investment yields, making Allstate an attractive play in the current rate environment.…
ALL
Allstate
$253.83
Related headlines
Investment Opinion: Should I buy ALL Today?
Based on the analysis, I rate Allstate as a Buy. The thesis is that the company is benefiting from a favorable macro environment and a period of low catastrophe losses, leading to exceptional earnings that are not fully reflected in the stock price. The analyst consensus is 'Buy' with an average target of $274.32, implying about 4.9% upside, but the high target of $334 suggests significant potential if conditions persist.
Sign up to view all
ALL 12-Month Price Forecast
The AI assessment is bullish, driven by the exceptional earnings performance and attractive valuation. However, the confidence is medium due to the cyclical nature of the insurance business and the risk of catastrophe losses normalizing. The key factors supporting the bullish stance are the strong earnings growth, low PE, and positive momentum. The main risk is that the current earnings are not sustainable, which could lead to a re-rating. If the company can demonstrate that the improved profitability is durable, the stock could re-rate higher. Conversely, if catastrophe losses spike, the stance would be downgraded to bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Allstate's 12-month outlook, with a consensus price target around $274.32 and implied upside of +8.1% versus the current price.
Average Target
$274.32
0 analysts
Implied Upside
+8.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$176 - $334
Analyst target range
The target price range spans from a low of $176.00 to a high of $334.00, with the average at $274.32. The wide spread of $158 suggests significant uncertainty about Allstate's future performance. The high target of $334 implies a 27.8% upside, likely assuming continued favorable catastrophe trends and strong policy growth, while the low target of $176 implies a 32.7% downside, possibly pricing in a return to higher catastrophe losses or competitive pressures. The recent downgrade by HSBC from Buy to Hold and KBW's move from Outperform to Market Perform indicate some caution, but the overall consensus remains positive, with the average target above the current price.
Bulls vs Bears: ALL Investment Factors
Allstate presents a compelling bull case driven by exceptional current earnings, strong momentum, and a favorable interest rate environment. The 'quiet catastrophe year' has boosted profitability to record levels, and the stock has responded with a 25% gain over the past year. However, the bear case hinges on the sustainability of these earnings, as the forward PE suggests the market expects a normalization. The wide analyst target range and recent downgrades highlight the uncertainty. Currently, the bull case has stronger evidence given the momentum and valuation, but the single most important tension is whether catastrophe losses remain low—if they do, the stock could re-rate higher; if they spike, earnings and the stock could fall sharply.
Bullish
- Exceptional earnings power: Q1 2026 EPS of $9.36 and net income of $2.46B represent a massive jump from Q1 2025's EPS of $2.14, driven by a 'quiet catastrophe year' and improved pricing. This demonstrates the operating leverage in Allstate's model when catastrophe losses normalize.
- Strong price momentum: The stock is up 25.3% over the past year and 26.0% over six months, trading at 94.3% of its 52-week range. This reflects strong investor confidence and a clear uptrend, supported by relative strength of 14.4% YTD versus the S&P 500.
- Attractive valuation metrics: With a trailing PE of 5.38x and a PEG ratio of 0.04, the stock appears deeply undervalued relative to its earnings growth. Even the forward PE of 9.51x is well below the market average, suggesting the market is pricing in a normalization that may be too pessimistic.
- High interest rate tailwind: Higher interest rates are boosting investment yields and underwriting margins for insurers. Allstate's net margin improved to 15.5% in Q1 2026 from 3.7% a year earlier, directly benefiting from this macro environment.
Bearish
- Earnings normalization risk: The trailing PE of 5.38x is artificially low due to a 'quiet catastrophe year.' The forward PE of 9.51x implies the market expects earnings to decline, and if catastrophe losses return to normal, EPS could drop significantly, pressuring the stock.
- Recent analyst downgrades: HSBC downgraded ALL from Buy to Hold and KBW moved from Outperform to Market Perform, signaling that some analysts see limited upside or increased risk. This could lead to further downgrades if Q2 results disappoint.
- High target price dispersion: The analyst target range spans from $176 to $334, a spread of $158 (60% of the current price). This wide dispersion indicates significant uncertainty about future performance, with the low target implying a 32.7% downside.
- Low beta but cyclical earnings: While the beta of 0.156 suggests low market correlation, insurance earnings are highly cyclical and sensitive to catastrophe events. A single major hurricane season could erase the earnings gains, making the stock riskier than the beta implies.
ALL Technical Analysis
Allstate's stock is in a strong uptrend, with a 1-year price change of +25.26% and a 6-month change of +25.97%. The current price of $261.41 sits at 94.3% of its 52-week range (low: $188.08, high: $277.22), indicating the stock is trading near its highs, reflecting robust momentum and investor confidence. This positioning near the top of the range suggests the market is rewarding the company's improving fundamentals, though it also raises the risk of overextension in the short term.
Beta
0.16
0.16x market volatility
Max Drawdown
-11.5%
Largest decline past year
52-Week Range
$188-$277
Price range past year
Annual Return
+22.9%
Cumulative gain past year
| Period | ALL Return | S&P 500 |
|---|---|---|
| 1m | +0.8% | +2.5% |
| 3m | +17.2% | +2.7% |
| 6m | +23.0% | +11.1% |
| 1y | +22.9% | +20.5% |
| ytd | +24.5% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALL Fundamental Analysis
Allstate's revenue growth has been steady, with Q1 2026 revenue of $16.94 billion, up 4.17% year-over-year. The multi-quarter trend shows revenue increasing from $15.62 billion in Q2 2024 to $16.94 billion in Q1 2026, indicating consistent, albeit moderate, growth. The Protection Services segment contributed $915 million in revenue, though the primary driver remains the core property-casualty business, which benefits from policy growth and improved pricing. This growth trajectory supports the investment case, as the company continues to expand its top line while managing costs effectively.
Quarterly Revenue
$16.9B
2026-03
Revenue YoY Growth
+4.2%
YoY Comparison
Gross Margin
45.3%
Latest Quarter
Free Cash Flow
$11.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALL Overvalued?
Given that Allstate is profitable, the PE ratio is the primary valuation metric. The trailing PE is 5.38x, while the forward PE is 9.51x, indicating that the market expects earnings to decline slightly in the coming year. This gap suggests that the current earnings are elevated due to favorable catastrophe experience, and the market is pricing in a normalization. The PEG ratio of 0.04 is extremely low, implying that the stock is undervalued relative to its growth prospects, though this metric should be interpreted with caution given the cyclical nature of insurance earnings.
PE
5.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~24x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Allstate's earnings are highly sensitive to catastrophe losses, which are inherently unpredictable. In Q1 2026, the company reported net income of $2.46B, a dramatic improvement from $595M in Q1 2025, but this was largely due to a 'quiet catastrophe year.' If catastrophe losses return to historical norms, earnings could revert to levels that do not support the current valuation. The company carries a debt-to-equity ratio of 0.24, which is manageable, but the current ratio of 0.37 indicates potential liquidity concerns, though this is typical for insurers. Additionally, the payout ratio of 11.2% suggests the dividend is well-covered, but a significant earnings decline could force a cut.